| 摘要 |
<p>The present invention provides a pharmaceutical composition, comprising a recombinant adenoviral vector encoding a pro-apoptotic Bax gene and a pharmaceutically acceptable carrier. Further is provided a method of treating an individual having a pathophysiological state, comprising the step of administering to said individual a pharmacologically effective dose of this composition.</p> |
